BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Week In Review: Lee’s Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc.

  October 13, 2014

   · 

  1 min read
• BioMidwest

  Prime Therapeutics Responds To FDA Approval Of Gilead’s Latest Hepatitis C Drug

  October 13, 2014

   · 

  3 min read
• Deals

  Oxford BioMedica PLC Acquires Windrush Court Office And Laboratory Facilities

  October 13, 2014

   · 

  2 min read
• Gedeon Richter Ltd. Launches Media-Soft Cloud Based Multichannel CRM Solution

  October 13, 2014

   · 

  2 min read
• Policy

  ProSensa Holding N.V. Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy

  October 13, 2014

   · 

  5 min read
• Business

  ACM Global Central Laboratory Names New Laboratory Manager At Shanghai Facility

  October 13, 2014

   · 

  3 min read
• Drug Development

  Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site For Phase 2 Clinical Trial Of New Treatment For Oral Mucositis

  October 13, 2014

   · 

  5 min read
• Business

  Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers

  October 13, 2014

   · 

  3 min read
• Drug Development

  Cardio3 BioSciences Receives Authorization To Enroll Patients In Switzerland In Its Phase 3 Clinical Trial Chart-1

  October 13, 2014

   · 

  4 min read
• Biotech Bay

  Kenneth Rainin Foundation Awards Over $2 Million In Grants For Cutting-Edge Inflammatory Bowel Disease Research

  October 13, 2014

   · 

  4 min read